Ionic Capital Management’s Coeptis Therapeutics Warrants COEPW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-93,559
Closed -$1.4K 117
2024
Q3
$1.4K Hold
93,559
﹤0.01% 141
2024
Q2
$2.11K Hold
93,559
﹤0.01% 143
2024
Q1
$2.39K Sell
93,559
-425,169
-82% -$17.4K ﹤0.01% 141
2023
Q4
$16.1K Hold
518,728
﹤0.01% 157
2023
Q3
$11.7K Hold
518,728
﹤0.01% 208
2023
Q2
$38.6K Hold
518,728
0.01% 186
2023
Q1
$85.4K Buy
518,728
+100,000
+24% +$12.9K 0.02% 195
2022
Q4
$41.8K Hold
418,728
0.01% 248
2022
Q3
$13K Hold
418,728
﹤0.01% 432
2022
Q2
$20K Hold
418,728
﹤0.01% 412
2022
Q1
$34K Hold
418,728
﹤0.01% 407
2021
Q4
$136K Sell
418,728
-9,752
-2% -$3.25K 0.02% 314
2021
Q3
$111K Sell
428,480
-8,702
-2% -$3.31K 0.01% 301
2021
Q2
$236K Hold
437,182
0.02% 300
2021
Q1
$188K Buy
437,182
+106,303
+32% +$99.8K 0.02% 252
2020
Q4
$457K Buy
+330,879
New +$305K 0.06% 152

Other funds holding COEPW

Ionic Capital Management's COEPW Position: Q4 2024 in Review

Ionic Capital Management sold out of Coeptis Therapeutics Warrants (COEPW) in Q4 2024, closing a stake of 93,559 shares — an estimated $1.4K sold.

Ionic Capital Management first reported a position in COEPW in Q4 2020 and held it in 16 quarters. The position peaked at $457K in Q4 2020. 13 funds tracked by Wall St. Rank hold COEPW as of Q4 2024.

  • Ionic Capital Management reported no remaining Coeptis Therapeutics Warrants position as of Q4 2024 after selling out during the quarter.
  • Ionic Capital Management sold 93,559 Coeptis Therapeutics Warrants shares in Q4 2024, an estimated $1.4K.
  • Ionic Capital Management first reported a position in Coeptis Therapeutics Warrants in Q4 2020 and held it in 16 quarters.
  • Ionic Capital Management's Coeptis Therapeutics Warrants position peaked at $457K in Q4 2020.
  • 13 funds tracked by Wall St. Rank held Coeptis Therapeutics Warrants as of Q4 2024.

Based on Ionic Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.